| Stereochemistry | ABSOLUTE |
| Molecular Formula | C22H22N6O3 |
| Molecular Weight | 418.4485 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]1(CCN(C1)C(=O)C=C)N2N=C(C#CC3=CC(OC)=CC(OC)=C3)C4=C(N)N=CN=C24
InChI
InChIKey=KEIPNCCJPRMIAX-HNNXBMFYSA-N
InChI=1S/C22H22N6O3/c1-4-19(29)27-8-7-15(12-27)28-22-20(21(23)24-13-25-22)18(26-28)6-5-14-9-16(30-2)11-17(10-14)31-3/h4,9-11,13,15H,1,7-8,12H2,2-3H3,(H2,23,24,25)/t15-/m0/s1
| Molecular Formula | C22H22N6O3 |
| Molecular Weight | 418.4485 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 3.9 nM [IC50] | |||
| 1.3 nM [IC50] | |||
| 1.6 nM [IC50] | |||
| 8.3 nM [IC50] |
